Journal of Neuroendocrinology
February 6, 2016
Petra Strajhar, Yasmin Schmid, Evangelia Liakoni et al.
129 citations
Lysergic acid diethylamide (LSD) is a serotonin 5‐hydroxytryptamine‐2A (5‐HT 2A ) receptor agonist that is used recreationally worldwide. Interest in LSD research in humans waned after the 1970s, although the use of LSD in psychiatric research and practice has recently gained increasing attention. LSD produces pronounced acute psychedelic effects, although its influence on plasma steroid levels...
Psychological Medicine
February 5, 2016
Robin Carhart-Harris, Mendel Kaelen, Mark Bolstridge et al.
301 citations
Background Lysergic acid diethylamide (LSD) is a potent serotonergic hallucinogen or psychedelic that modulates consciousness in a marked and novel way. This study sought to examine the acute and mid-term psychological effects of LSD in a controlled study. Method A total of 20 healthy volunteers participated in this within-subjects study. Participants received LSD (75 µ g, intravenously) on one...
Behavioural Brain Research
2016
Evan J. Kyzar, Adam Michael Stewart, Allan V. Kalueff
Serotonin (5-HT) plays a crucial role in the brain, modulating mood, cognition and reward. The serotonin transporter (SERT) is responsible for the reuptake of 5-HT from the synaptic cleft and regulates serotonin signaling in the brain. In humans, SERT genetic variance is linked to the pathogenesis of various psychiatric disorders, including anxiety, autism spectrum disorders (ASD) and...
Journal of Psychopharmacology
2016
Jana Speth, Clemens Speth, Mendel Kaelen et al.
119 citations
This paper reports on the effects of LSD on mental time travel during spontaneous mentation. Twenty healthy volunteers participated in a placebo-controlled crossover study, incorporating intravenous administration of LSD (75 μg) and placebo (saline) prior to functional magnetic resonance imaging (fMRI). Six independent, blind judges analysed mentation reports acquired during structured...
Boom
December 1, 2015
Jason S. Sexton
The California spirit of innovation and transmogrification showed itself when Alex Grey’s “Purple Jesus” oil-on-wood painting made its way to San Francisco. It was purchased by a shrewd collector, Mark McCloud, who turned the image into what became Purple Jesus Blotter in the early 1990s. Through a complicated history and even more complicated philosophy of psychedelia, the lasting significance...
Drug Testing and Analysis
October 12, 2015
Simon D. Brandt, Pierce V. Kavanagh, Folker Westphal et al.
79 citations
1‐Propionyl‐ d ‐lysergic acid diethylamide hemitartrate (1P‐LSD) has become available as a ‘research chemical’ in the form of blotters and powdered material. This non‐controlled derivative of d ‐lysergic acid diethylamide (LSD) has previously not been described in the published literature despite being closely related to 1‐acetyl‐LSD (ALD‐52), which was developed in the 1950s. This study...
Psychopharmacology
October 2015
Mendel Kaelen, Frederick S. Barrett, Leor Roseman et al.
There is renewed interest in the therapeutic potential of psychedelic drugs such as lysergic acid diethylamide (LSD). LSD was used extensively in the 1950s and 1960s as an adjunct in psychotherapy, reportedly enhancing emotionality. Music is an effective tool to evoke and study emotion and is considered an important element in psychedelic-assisted psychotherapy; however, the hypothesis that...
Jurnal e-Biomedik
September 11, 2015
Alfred Budiono, Benny Wantouw, Lusiana Satiawati
1 citation
Abstract: Lysergic Acid Diethylamide (LSD) is a psychotropic drug that can be found in glue. This substance acts as serotonine and dopamine agonists and results in hallucinogenic effect. LSD is a main raw material in glue and commonly available in an affordable price. Moreover, LSD also has a direct impact on spermatozoa motility and morphology. This study aimed to obtain the change in the...
Canadian Medical Association Journal
August 4, 2015
Erika Dyck
25 citations
Psychedelics fell from medical grace nearly half a century ago, but recent activity suggests that some researchers have "high hopes" for their return.[1][1],[2][2] Over 60 years ago, Albert Hofmann at Sandoz Pharmaceutical Laboratories in Switzerland first synthesized lysergic acid diethylamide
The International Journal of Neuropsychopharmacology
June 24, 2015
Patrick C. Dolder, Yasmin Schmid, Manuel Haschke et al.
110 citations
These first data on the pharmacokinetics and concentration-effect relationship of oral lysergic acid diethylamide are relevant for further clinical studies and serve as a reference for the assessment of intoxication with lysergic acid diethylamide.